Spatial dissection of tumour microenvironments in gastric cancers reveals the immunosuppressive crosstalk between CCL2+ fibroblasts and STAT3 -activated macrophages
2024/11/23 by Sung Hak Lee, Dagyeong Lee, Junyong Choi +17 · 25 citations
Immunology and Microbiology · Biochemistry, Genetics and Molecular Biology · Medicine · #Immune cells in cancer #Single-cell and spatial transcriptomics #Cancer Cells and Metastasis
paper · pdf · doi:10.1136/gutjnl-2024-332901
Abstract
Background A spatially resolved, niche-level analysis of tumour microenvironments (TME) can provide insights into cellular interactions and their functional impacts in gastric cancers (GC). Objective Our goal was to translate the spatial organisation of GC ecosystems into a functional landscape of cellular interactions involving malignant, stromal and immune cells. Design We performed spatial transcriptomics on nine primary GC samples using the Visium platform to delineate the transcriptional landscape and dynamics of malignant, stromal and immune cells within the GC tissue architecture, highlighting cellular crosstalks and their functional consequences in the TME. Results GC spatial transcriptomes with substantial cellular heterogeneity were delineated into six regional compartments. Specifically, the fibroblast-enriched TME upregulates epithelial-to-mesenchymal transformation and immunosuppressive response in malignant and TME cells, respectively. Cell type-specific transcriptional dynamics revealed that malignant and endothelial cells promote the cellular proliferations of TME cells, whereas the fibroblasts and immune cells are associated with procancer and anticancer immunity, respectively. Ligand-receptor analysis revealed that CCL2 -expressing fibroblasts promote the tumour progression via JAK-STAT3 signalling and inflammatory response in tumour-infiltrated macrophages. CCL2+ fibroblasts and STAT3 -activated macrophages are co-localised and their co-abundance was associated with unfavourable prognosis. We experimentally validated that CCL2+ fibroblasts recruit myeloid cells and stimulate STAT3 activation in recruited macrophages. The development of immunosuppressive TME by CCL2+ fibroblasts were also validated in syngeneic mouse models. Conclusion GC spatial transcriptomes revealed functional cellular crosstalk involving multiple cell types among which the interaction between CCL2+ fibroblasts and STAT3 -activated macrophages plays roles in establishing immune-suppressive GC TME with potential clinical relevance.
Cited by
- Blood TCTP as a potential biomarker associated with immunosuppressive features and poor clinical outcomes in metastatic gastric cancer. [europepmc]
- Single-cell profiling uncovers the intricate pathological niche diversity in brain, lymph node, bone, and adrenal metastases of lung cancer. [europepmc]
- Oral ENPP1 inhibitor designed using generative AI as next generation STING modulator for solid tumors. [europepmc]
- Identification of a stromal immunosuppressive barrier orchestrated by SPP1 + /C1QC + macrophages and CD8 + exhausted T cells driving gastric cancer immunotherapy resistance. [europepmc]
- Decoding tumor heterogeneity: A spatially informed pan-cancer analysis of the tumor microenvironment. [europepmc]
- Cancer-Associated Fibroblasts: Origin, Classification, Tumorigenicity, and Targeting for Cancer Therapy. [europepmc]
- The Anti-Cancer Potential of Genistein: Single-Cell RNA Sequencing Analysis and Spatial Transcriptome Reveal That Genistein Targets HSD17B1 to Inhibit the Progression of Gastric Adenocarcinoma. [europepmc]
- Inflammatory factors collaboratively link Helicobacter pylori -induced gastritis to gastric cancer. [europepmc]
- Comprehensive molecular characterization of high-stemness gastric cancer cells using single-cell transcriptomics, spatial mapping, and machine learning. [europepmc]
- Cancer-associated fibroblasts: central players in cancer hallmarks and therapeutic resistance. [europepmc]
- Spatial atlas of gastric cancer reveals macrophage-driven stromal activation via ICAM1⁺ smooth muscle cells. [europepmc]
- LncRNA NEAT1 promotes immunosuppression in gastric cancer under endoplasmic reticulum stress by maintaining the M 6 A methylation of SEMA3A in CAFs. [europepmc]
- Advances in Spatial Multi-Omics in Gastric Cancer. [europepmc]
- Translational advances in gastric cancer: integrating biomarkers, novel therapies, and microenvironment remodeling in 2025. [europepmc]
- SpaHE-Infil: A spatial heterogeneity framework for decoding TME infiltration from H&E-stained slides. [europepmc]
- Dissecting molecular heterogeneity in primary gastric cancer by IGFBP7-related analysis. [europepmc]
- Spatial multi-omics technologies in gastric cancer: applications and advances. [europepmc]
- Comprehensive Overview of Gastric Cancer Immunohistochemistry: Key Biomarkers, Advanced Detection Methods, and Perspectives. [europepmc]
- Tumor Budding in Gastric Carcinoma: Beyond Counting Cells at the Invasive Front-A Review of Current Evidence and Biological Perspectives. [europepmc]
- Integrative Multiomics Analysis Reveals Tumor-Associated Macrophage Heterogeneity and a Prognostic Signature in Gastric Cancer. [europepmc]
- Gastric Cancer: Pathobiology and Therapeutics. [europepmc]
- Architectural Refuges: Mapping Spatial Heterogeneity and Niche-Mediated Drug Resistance in Gastric and Esophageal Adenocarcinomas. [europepmc]
- The invasive front in hepatocellular carcinoma: toward a tumor-CAF-macrophage metabolic interface. [europepmc]
- From Primary Tumor to Peritoneal Niche: Microenvironmental Divergence in Gastric Cancer Peritoneal Metastasis. [europepmc]
- Spatial immune archetypes in gastric and colorectal cancer: a proposed conceptual framework for immunotherapy resistance and therapeutic remodeling [europepmc]
Related